Vivanta Industries sets Sep 30 AGM to approve new MOA, AOA
- Vivanta Industries schedules its 13th AGM for September 30, 2026, via video conferencing
- Shareholders to approve new MOA and AOA aligned with the Companies Act, 2013
- Related-party transaction cap set at ₹100 crore for FY27, representing ~40% of turnover
- Borrowing limit under Section 180(1)(C) increased from ₹90 crore to ₹105 crore
- Remote e-voting window opens on September 26 and closes on September 29, 2026

*this image is generated using AI for illustrative purposes only.
Vivanta Industries has scheduled its 13th Annual General Meeting (AGM) for September 30, 2026. The meeting will be held via video conferencing at 4:00 pm IST. Shareholders on record as of September 23, 2026, are eligible to vote.
The Board of Directors approved the draft notice and key resolutions in its meeting held on September 2, 2026. The session also saw the approval of standalone and consolidated financial statements for FY26, along with the Board’s Report and Secretarial Audit Report.
Key Agenda Items
The AGM will transact both ordinary and special business. Ordinary business includes the adoption of audited financial statements for the fiscal year ended March 31, 2026, and the re-appointment of Mr. Jainil R. Bhatt as a director retiring by rotation.
Special business items focus on regulatory compliance and capital structure adjustments:
- Adoption of new Memorandum of Association (MOA) and Articles of Association (AOA) to align with the Companies Act, 2013.
- Approval of material related-party transactions (RPTs) for FY27 and FY28.
- Revision of borrowing authority under Section 180(1)(C).
- Approval for loans, guarantees, and securities under Sections 185 and 186 of the Companies Act, 2013.
Related-Party Transactions
The company seeks shareholder approval for RPTs with specified related parties, including promoters, directors, and group entities. The aggregate value of these transactions is capped at ₹100 crore during FY26-2027. This limit represents approximately 39.98% of the annual consolidated turnover based on FY25-2026 figures.
The related parties include H. A. Parikh (Managing Director), Jainil R. Bhatt (Director), and various promoter-linked entities such as Vivanza Biosciences Limited and Kesar Pharma Limited. These transactions are proposed to be undertaken on an arm’s length basis in the ordinary course of business.
Capital Structure and Borrowing Limits
The Board proposes to increase the overall borrowing limit from ₹90 crore to ₹105 crore under Section 180(1)(C) of the Companies Act, 2013. This revision aims to meet current book size requirements and future working capital needs.
Additionally, shareholders will vote on enabling resolutions for:
- Loans, guarantees, or security for subsidiaries or associate companies up to an aggregate limit of ₹50 crore under Section 185.
- Loans, investments, or guarantees under Section 186, allowing amounts up to ₹100 crore over and above the statutory limits of paid-up capital and free reserves.
E-Voting and Meeting Details
Remote e-voting will commence on September 26, 2026, at 9:00 am and conclude on September 29, 2026, at 5:00 pm. The facility is provided by National Securities Depository Limited (NSDL). Physical attendance is dispensed with, and proxy appointments are not available for this virtual meeting.
Historical Stock Returns for Vivanta Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.65% | -1.10% | +2.29% | +7.83% | -28.97% | +8.48% |
How might the approval of ₹100 crore in related-party transactions with entities like Vivanza Biosciences and Kesar Pharma impact Vivanta's operational synergies or profit margins in FY27?
What specific growth initiatives or working capital requirements justify the proposed increase in borrowing limits from ₹90 crore to ₹105 crore?
Could the new Memorandum and Articles of Association signal a strategic shift in corporate governance or business scope that may affect future M&A activities?


































